PHYH
Basic information
Region (hg38): 10:13277796-13302412
Links
Phenotypes
GenCC
Source:
- adult Refsum disease (Strong), mode of inheritance: AR
- adult Refsum disease (Definitive), mode of inheritance: AR
- adult Refsum disease (Supportive), mode of inheritance: AR
- adult Refsum disease (Definitive), mode of inheritance: AR
- phytanoyl-CoA hydroxylase deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Refsum disease | AR | Biochemical; Cardiovascular; Pharmacogenomic | Dietary measures (high calorie diet with phytanic acid restriction) may be beneficial; Surveillance can allow early diagnosis and treatment of cardiac manifestsations (eg, cardiac arrhythmias, cardiomyopathy); Plasmapheresis/lipid apheresis may be indicated in severe situations; Certain agents/circumstances (eg, fasting, ibuprofen) should be avoided | Audiologic/Otolaryngologic; Biochemical; Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Ophthalmologic | 13045168; 18140089; 4159604; 85164; 6160883; 2452736; 9326939; 9326940; 10767344; 17905308; 20301527; 20547622; 22156782 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (23 variants)
- Phytanic acid storage disease (6 variants)
- Refsum syndrome (1 variants)
- Refsum disease, adult, 1 (1 variants)
- Retinitis pigmentosa (1 variants)
- PHYH-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PHYH gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 95 | 101 | ||||
missense | 133 | 142 | ||||
nonsense | 10 | 19 | ||||
start loss | 2 | |||||
frameshift | 10 | 13 | 23 | |||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 15 | 17 | ||||
splice region | 11 | 15 | 26 | |||
non coding | 11 | 75 | 30 | 116 | ||
Total | 23 | 40 | 155 | 171 | 34 |
Highest pathogenic variant AF is 0.000177
Variants in PHYH
This is a list of pathogenic ClinVar variants found in the PHYH region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-13277802-G-A | Phytanic acid storage disease | Uncertain significance (Jan 13, 2018) | ||
10-13277867-T-C | Phytanic acid storage disease | Uncertain significance (Jan 12, 2018) | ||
10-13277884-T-C | Phytanic acid storage disease | Uncertain significance (Jan 12, 2018) | ||
10-13278048-C-A | Phytanic acid storage disease | Uncertain significance (Jan 12, 2018) | ||
10-13278111-GT-G | Phytanic acid storage disease | Benign (Aug 10, 2019) | ||
10-13278111-G-GT | Benign (Aug 22, 2019) | |||
10-13278113-T-G | Phytanic acid storage disease | Uncertain significance (Jan 13, 2018) | ||
10-13278236-C-T | Phytanic acid storage disease | Benign (Aug 07, 2018) | ||
10-13278254-C-T | Phytanic acid storage disease | Likely benign (Jan 13, 2018) | ||
10-13278276-G-A | Phytanic acid storage disease | Uncertain significance (Jan 12, 2018) | ||
10-13278279-A-C | Phytanic acid storage disease | Likely benign (Jan 13, 2018) | ||
10-13278304-A-G | PHYH-related disorder | Likely benign (Jan 08, 2024) | ||
10-13278305-A-AGAT | Nonsyndromic cleft lip palate • not specified | Conflicting classifications of pathogenicity (Mar 01, 2024) | ||
10-13278307-A-T | Inborn genetic diseases | Uncertain significance (May 08, 2023) | ||
10-13278308-T-C | Uncertain significance (Dec 02, 2021) | |||
10-13278309-T-C | Phytanic acid storage disease | Uncertain significance (Jul 30, 2019) | ||
10-13278312-T-G | Uncertain significance (Apr 28, 2022) | |||
10-13278327-C-G | Inborn genetic diseases | Uncertain significance (Oct 04, 2022) | ||
10-13278332-C-G | Uncertain significance (Mar 29, 2021) | |||
10-13278332-C-T | Uncertain significance (Dec 11, 2023) | |||
10-13278333-G-A | Uncertain significance (Jun 14, 2022) | |||
10-13278335-G-C | Uncertain significance (Apr 11, 2022) | |||
10-13278337-T-C | Likely benign (Jan 07, 2023) | |||
10-13278338-C-A | Uncertain significance (Jul 12, 2022) | |||
10-13278338-C-T | Phytanic acid storage disease • PHYH-related disorder | Likely benign (Jan 27, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PHYH | protein_coding | protein_coding | ENST00000263038 | 9 | 24617 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000238 | 0.744 | 125689 | 0 | 59 | 125748 | 0.000235 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0310 | 194 | 195 | 0.994 | 0.0000113 | 2245 |
Missense in Polyphen | 53 | 53.778 | 0.98554 | 597 | ||
Synonymous | 0.292 | 72 | 75.2 | 0.957 | 0.00000522 | 619 |
Loss of Function | 1.20 | 11 | 16.2 | 0.678 | 6.96e-7 | 200 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000297 | 0.000297 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.000462 | 0.000462 |
European (Non-Finnish) | 0.000317 | 0.000316 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Converts phytanoyl-CoA to 2-hydroxyphytanoyl-CoA.;
- Pathway
- Peroxisome - Homo sapiens (human);Oxidation of Branched Chain Fatty Acids;Refsum Disease;Phytanic Acid Peroxisomal Oxidation;Metabolism of lipids;Metabolism of proteins;Alpha-oxidation of phytanate;Peroxisomal lipid metabolism;Metabolism;Peroxisomal protein import;Fatty acid metabolism;Phytanic acid peroxisomal oxidation;TYSND1 cleaves peroxisomal proteins;fatty acid α-oxidation
(Consensus)
Recessive Scores
- pRec
- 0.229
Intolerance Scores
- loftool
- 0.119
- rvis_EVS
- 0.62
- rvis_percentile_EVS
- 83.36
Haploinsufficiency Scores
- pHI
- 0.0601
- hipred
- N
- hipred_score
- 0.377
- ghis
- 0.476
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.670
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Phyh
- Phenotype
- immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); reproductive system phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);
Gene ontology
- Biological process
- fatty acid alpha-oxidation;2-oxoglutarate metabolic process;protein targeting to peroxisome;isoprenoid metabolic process;methyl-branched fatty acid metabolic process
- Cellular component
- peroxisome;peroxisomal matrix;cytosol
- Molecular function
- protein binding;ferrous iron binding;carboxylic acid binding;L-ascorbic acid binding;cofactor binding;phytanoyl-CoA dioxygenase activity